Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: J Neurosci Res. 2019 Sep 5;97(12):1503–1514. doi: 10.1002/jnr.24522

COMPARTMENTAL FUNCTION AND MODULATION OF THE STRIATUM

Eric M Prager 1, Joshua L Plotkin 1,*
PMCID: PMC6801090  NIHMSID: NIHMS1537908  PMID: 31489687

Abstract

The striatum plays a central role in guiding numerous complex behaviors, ranging from motor control to action selection and reward learning. The diverse responsibilities of the striatum are reflected by the complexity of its organization. In this review we will summarize what is currently known about the compartmental layout of the striatum, an organizational principle that is crucial for allowing the striatum to guide such a diverse array of behaviors. We will focus on the anatomical and functional properties of striosome (patch) and matrix compartments of the striatum, and how the engagement of these compartments is uniquely controlled by their afferents, intrinsic properties and neuromodulation. We will give examples of how advances in technology have opened the door to functionally dissecting the striatum’s compartmental design, and close by offering thoughts on the future and relevance for human disease.

Keywords: Striosome, striatum, dopamine, Substance P, enkephalin, acetylcholine


The execution of precise movements and action-based sequences requires the convergence of inputs from cortical and subcortical structures onto the striatum, the primary input nucleus to the basal ganglia (Gerfen & Surmeier, 2011; Jin & Costa, 2015). These inputs target GABAergic spiny projection neurons (SPNs), the predominant striatal neuronal class, as well as a menagerie of interneurons, in a topographically organized manner (Assous & Tepper, 2019; Ebrahimi, Pochet, & Roger, 1992; Gerfen & Surmeier, 2011); coordinated engagement and interaction of these striatal neurons shapes SPN activity and thus striatal output and behavior (Amemori, Gibb, & Graybiel, 2011; Graybiel, 2008). SPNs account for 90–95% of all striatal neurons, and can be subdivided into at least two intermingled populations based on their axonal projection targets and expression of releasable peptides and dopamine receptors (Bolam, Hanley, Booth, & Bevan, 2000; Gerfen et al., 1990; Gerfen & Wilson, 1996; Gerfen & Young, 1988; Kawaguchi, Wilson, & Emson, 1990; Le Moine, Normand, & Bloch, 1991; Onn, Berger, & Grace, 1994; Plotkin & Goldberg, 2018; Smith et al., 2016). In general, “direct pathway” SPNs (dSPNs) project directly to the output nuclei of the basal ganglia (though they also send axon “bridging” collaterals to the external globus pallidus (GPe) (Cazorla et al., 2014; Kawaguchi et al., 1990)) and express D1 dopamine receptors and substance P (SP); “indirect pathway” SPNs (iSPNs) project to the GPe (thus connecting to the basal ganglia output nuclei indirectly) and express D2 dopamine receptors and enkephalin (ENK) (Albin, Young, & Penney, 1989; Gerfen, 2006; Gong et al., 2003; Kravitz, Tye, & Kreitzer, 2012; Kreitzer, 2009; Wall, De La Parra, Callaway, & Kreitzer, 2013). This organization has several consequences that are central to basal ganglia function and control of movement and action selection: 1) dSPN activity promotes disinhibition of the thalamus and action initiation, while iSPN activity promotes the opposite and 2) fluctuations in striatal dopamine will have opposing effects on dSPNs and iSPNs (Albin et al., 1989; Alexander & Crutcher, 1990; Gerfen & Surmeier, 2011; Kravitz et al., 2012).

In addition to direct and indirect pathways, the striatum is organized into histochemically defined compartments, known as striosomes (or patches) and matrix (Gerfen, 1984, 1992a; Gerfen, Baimbridge, & Miller, 1985; Graybiel & Ragsdale, 1978; Herkenham, Edley, & Stuart, 1984; Jimenez-Castellanos & Graybiel, 1989; Pert, Kuhar, & Snyder, 1976). Both compartments contain dSPNs and iSPNs, but the compartmental activities of these SPNs have been associated with distinct behaviors. For example, while striosomes only occupy about 10–15% of the total striatal volume (Davis & Puhl, 2011; Desban, Kemel, Glowinski, & Gauchy, 1993; Johnston, Gerfen, Haber, & van der Kooy, 1990; Miyamoto, Katayama, Shigematsu, Nishi, & Fukuda, 2018; Morigaki & Goto, 2016), engagement of neurons within these compartments has been linked to the generation of drug-induced motor stereotypies, the selection of high-cost/high-value reward options and encoding expected outcomes during learning (Amemori et al., 2011; Bloem, Huda, Sur, & Graybiel, 2017; Canales & Graybiel, 2000; Friedman et al., 2015; Yoshizawa, Ito, & Doya, 2018).

How is compartment-specific activity of SPNs achieved in a behaviorally-relevant way? This likely involves an interplay between 1) selective activation of afferents, 2) modulation of neuronal activity and synaptic transmission by neuromodulators such as dopamine (DA), acetylcholine (ACh) and opioid peptides, and 3) interneuron mediated intra- and inter-compartmental signaling (Abudukeyoumu, Hernandez-Flores, Garcia-Munoz, & Arbuthnott, 2018; Brimblecombe & Cragg, 2017; Brimblecombe et al., 2018; Crittenden & Graybiel, 2011; Friedman et al., 2015). Despite evidence supporting the importance of compartment-specific striatal output in shaping behavior (Amemori et al., 2011; Bloem et al., 2017; Canales, 2005; Friedman et al., 2015), progress towards understanding the underlying mechanisms had largely been impeded by technical limitations. This is due to the low percentage of striosomal neurons and inability to visualize compartmental organization in live tissue. New tools allowing the visualization and manipulation of compartment-specific neurons have now given unprecedented functional access to this circuitry. While not an exhaustive review of the literature, the goal of this review is twofold. First, we will provide an update on the histochemical organization of the striatum and compartment-specific connectivity. Second, we will present examples of how newly available genetic and imaging tools have shed light on the functional and modulatory mechanisms that shape compartment-specific activity.

Etiology of Striatal Compartmental Organization

Early studies examining acetylcholinesterase distribution in the striatum of adult humans, rhesus monkeys and cats revealed distinct compartments of low cholinesterase activity (Graybiel & Ragsdale, 1978). It soon became apparent that this histological pattern represented a coordinated organizational principle of the mature striatum, with neighboring neurons having more in common than just the local acetylcholinesterase activity level. For example, acetylcholinesterase-poor regions (striosomes/patches) also express high levels of the p-opioid receptor (MOR), while acetylcholinesterase-rich regions (matrix) express high levels of the Ca2+-binding protein calbindin (Herkenham & Pert, 1981; Pert et al., 1976). Numerous other striatal proteins and genes are preferentially expressed in striosomes vs matrix-exhaustive lists are available elsewhere (Brimblecombe & Cragg, 2017; Crittenden & Graybiel, 2011). In general, the relative expression of dSPN-specific proteins is higher in striosomes and iSPN-specific proteins higher in matrix (Fujiyama et al., 2011; Guttenberg, Klop, Minami, Satoh, & Voorn, 1996; Levesque & Parent, 2005; Miyamoto et al., 2018). Supporting this observation, single cell tracing studies of striosome SPNs have reported higher percentages of neurons with axonal projections to basal ganglia output structures than to intermediate nuclei (Fujiyama et al., 2011; Levesque & Parent, 2005). This has led to an oft-cited dogma that striosomes are predominantly composed of dSPNs. This dogma, however, should be qualified. First, the matrix contains approximately equal numbers of dSPNs and iSPNs, so the contribution of the matrix to the direct pathway should not be sold short. Second, Miyamoto and colleagues recently demonstrated that striosomes can be classified into 5 types based on MOR, SP and ENK expression, suggesting that there may be heterogeneity in both striosome function and their primary pathway-associated targets (Miyamoto et al., 2018). Indeed, SP-rich striosomes (which are primarily found in the medial striatum in rodents) may contain up to 70% dSPNs, but the percentage of dSPNs is far lower (as low as 40%) in other striosome regions (Miyamoto et al., 2018).

The groundwork for the striatum’s compartmental organization is laid embryonically. In fact, striosomes represent some of the oldest and earliest assembled circuit components in the striatum. Striatal cells migrate from the lateral ganglionic eminence in two distinct waves, beginning around embryonic days 9.5 to 13.5 in rodents (Kelly et al., 2018; Tinterri et al., 2018). The cells in the first wave ultimately correspond to striosomal SPNs and migrate to their destinations around the same time as the earliest cortical (layer 6) neurons do, putting them in position to receive early corticostriatal as well as early thalamostriatal inputs (Fishell & van der Kooy, 1987; Graybiel, 1984; Graybiel & Hickey, 1982; Hagimoto, Takami, Murakami, & Tanabe, 2017; Moon Edley & Herkenham, 1984; Nakamura, Hioki, Fujiyama, & Kaneko, 2005; Song & Harlan, 1994). Immature striosomes are also the recipients of the earliest dopaminergic inputs. Dopaminergic nigrostriatal fibers initially form “dopamine islands” within the striatum, before spreading to the more homogenous distribution seen in the adult (Olson, Seiger, & Fuxe, 1972; Tennyson et al., 1972). These dopamine islands overlap with immature striosome compartments (Davis & Puhl, 2011; Graybiel, Pickel, Joh, Reis, & Ragsdale, 1981; Hagimoto et al., 2017; Miura, Saino-Saito, Masuda, Kobayashi, & Aosaki, 2007). Once positioned, striosome cells become mostly stationary and cluster together, whereas matrix cells continue to actively migrate in a multidirectional manner during late embryonic development (Hagimoto et al., 2017). The homogenous mix of dSPNs and iSPNs observed in adults is this result of a parallel, active intermixing of iSPNs (Tinterri et al., 2018). While striosomes form a continuous labyrinthine network that extends through the striatum (Graybiel & Ragsdale, 1978), it should be noted that recent work has discovered the presence of scattered SPNs within the matrix (termed “exo-patches”) that are more similar to striosome than matrix SPNs in terms of genetic profiles, birth date, synaptic connectivity and modulation by neuropeptides (Crittenden & Graybiel, 2011; Newman, Liu, & Graybiel, 2015; Smith et al., 2016). It should also be noted that the mature morphological appearance of compartmentalization varies by region, with striosomes in dorsal and central striatal regions having canonical “patchy” appearances, and those ventrally often appearing more like “swirls” (Brimblecombe & Cragg, 2017). The precise function and etiology of exo-patches and morphological differences in compartmentalization remain to be determined.

Compartment Specific Afferent and Efferent Pathways

A feature of striatal compartmental organization is the segregation of striatal inputs and outputs. Decades of research exploring the compartmental targets of striatal afferents uncovered several themes. First, though some overlap certainly exists, afferents are often categorically segregated: in the dorsal striatum limbic-associated cortical and subcortical regions (including portions of the prelimbic, orbitofrontal and anterior insular cortices and basolateral nuclei of the amygdala) preferentially innervate striosomes, whereas projections from somatosensory and motor cortices preferentially innervate the matrix. Second, just as not all striosomes are histochemically homogenous, compartment-specific innervation patterns vary across striatal regions (Canales, 2005; Donoghue & Herkenham, 1986; Eblen & Graybiel, 1995; Flaherty & Graybiel, 1994; Friedman et al., 2015; Gerfen, 1984, 1985, 1989; Graybiel & Ragsdale, 1978; Kincaid & Wilson, 1996; Levesque, Charara, Gagnon, Parent, & Deschenes, 1996; Ragsdale & Graybiel, 1988, 1990). Despite the wealth of evidence for compartmental segregation of striatal afferents, recent work employing new methodologies has called much of this into question (we refer the reader to Brimblecombe and Cragg (2017) and Gerfen et al. (2013) for further information about new mouse lines used to isolate and interrogate compartments and their afferents/efferents). Using bacterial artificial chromosome (BAC) mice that preferentially express cre recombinase in striosomes vs matrix neurons and cutting-edge viral tracing techniques, Smith and colleagues reported that afferents from most cortical regions showed minimal compartmental preference (Smith et al., 2016). They did find, however, that subcortical regions such as the septum, hypothalamus and bed nucleus of the stria terminalis preferentially project to the striosomes. The reason for these discrepancies is not clear, but likely relates to methodological differences. For example, the retroviral tracing techniques employed in the latter study are well suited to detect differences in the number of presynaptically connected neurons, but lack sensitivity in detecting differences in synapse number between connected neurons. Consistent with this, recent studies utilizing viral tracing techniques that functionally and visually label corticostriatal axonal fields detect preferential connectivity between the prelimbic cortex and striosomes and anterior cingulate cortex and matrix (Friedman et al., 2017; Friedman et al., 2015).

Both compartments contain dSPNs and iSPNs that project to the substantia nigra pars reticulata (SNr) / internal globus pallidus (GPi; entopeduncular nucleus in mice) and GPe, respectively, and hence contribute to canonical direct and indirect pathways (Fujiyama et al., 2011). Due to the sheer numbers of matrix vs striosome SPNs, however, the source of GPe/SNr/GPi synaptic inhibition is likely biased towards SPNs residing in the matrix (Fujiyama et al., 2011; Gerfen & Young, 1988; Jimenez-Castellanos & Graybiel, 1989; Levesque & Parent, 2005; Rajakumar, Elisevich, & Flumerfelt, 1993; Tokuno, Chiken, Kametani, & Moriizumi, 2002). But striosomal dSPNs may also innervate other targets, endowing them with the capacity to influence unique aspects of behavior. Work in non-human primates has shown that striosome SPNs innervate ventral pallidum neurons and “border neurons” situated at the edge of the GPi, which then inhibit or excite neurons within the lateral habenula, respectively. This disynaptic circuit offers a mechanism by which striosomal output can feasibly guide negative reward prediction and motivational decision-making (Hong et al., 2019; Hong & Hikosaka, 2013). It was also discovered early on that in addition to targeting the output nuclei of the basal ganglia, many striosome dSPNs directly target dopaminergic neurons of the substantia nigra pars compacta (SNc) (Gerfen, 1985; Jimenez- Castellanos & Graybiel, 1987). While a recent study using cre-dependent viral tracing techniques to target SNc neurons suggests that a population of matrix and exo-patch SPNs may do the same (Smith et al., 2016), 1) the density of retrogradely labeled SPNs projecting to the SNc is higher in striosomes, and 2) viral labeling of BAC transgenic mice preferentially expressing cre recombinase in striosome vs matrix neurons has demonstrated differential outputs to the SNc (Gerfen, Paletzki, & Heintz, 2013; Smith et al., 2016). Furthermore, it is clear that axon terminals originating from striosome SPNs form tightly wound associations with the ventrally extending dopaminergic dendrites of SNc neurons. Termed “striosome-dendron bouquets”, these associations have been proposed to represent computational units allowing striosomal regulation of dopaminergic neurons (Crittenden et al., 2016). Though the precise function of striosome-dendron bouquets is unknown, one possibility is that striosomal axons within the bouquets regulate local dopamine release from dendrites within the SNr. An alternate (and not mutually exclusive) possibility is that the bouquets serve as a homeostat, whereby elevations in striatal dopamine will alter the activity of striosomal neurons projecting to the SNc, leading to direct inhibition of dopaminergic neurons and thus reducing dopamine release in the striatum.

Inter-compartmental Communication

SPN dendrites and axon collaterals generally respect compartmental borders, resulting in minimal inter- compartmental synaptic communication (Bolam, Izzo, & Graybiel, 1988; Fujiyama et al., 2011; Kawaguchi, Wilson, & Emson, 1989; Lopez-Huerta et al., 2016; Penny, Wilson, & Kitai, 1988). Many local striatal interneurons, however, have dendrites and axons that freely traverse compartmental borders, positioning them to serve as a functional bridge between compartments. Indeed, though widely distributed (and often at higher densities in the matrix), cholinergic interneurons (CINs), parvalbumin-expressing fast-spiking interneurons, neuropeptide Y- expressing interneurons and calretinin- expressing interneurons are frequently located along striosomal borders in what have been termed “peristriosomal boundaries”, anatomically and functionally defined micro-regions that may potentially shepherd information flow between compartments (Bernacer, Prensa, & Gimenez-Amaya, 2012; Brimblecombe & Cragg, 2015, 2017; Cowan, Wilson, Emson, & Heizmann, 1990; Kubota & Kawaguchi, 1993; Matamales, Gotz, & Bertran-Gonzalez, 2016; Rushlow, Naus, & Flumerfelt, 1996). A great deal is known about how interneurons guide circuit function within compartments, or at least in the presumptive matrix (Assous & Tepper, 2019; Banghart, Neufeld, Wong, & Sabatini, 2015; Crittenden et al., 2017), and clues suggesting how local microcircuitry preferentially impacts striosome vs matrix SPN activity are emerging (Banghart et al., 2015; Friedman et al., 2015). But the precise role that interneurons play in functionally linking striosome and matrix circuits is a crucial area for future study (see (Amemori et al., 2011).

Functional Differences between Striosome and Matrix SPNs

Compartmental Differences in Intrinsic Excitability

Because 1) technical limitations typically impede the targeted interrogation of compartments in live striatal tissue and 2) there is a substantial volume disparity between striosomes and matrix, most published studies of striatal function likely reflect phenomena occurring in the matrix. The first study to systematically compare the electrophysiological properties of SPNs in striosomes vs matrix employed intracellular recordings followed by post-hoc histological identification in rat brain slices (Kawaguchi et al., 1989). While this heroic study reported overall similarities in membrane properties and firing characteristics, more recent studies employing patch clamp techniques in genetically-labeled mice have begun to uncover differences. One theme that has arisen is that SPNs in striosomes are intrinsically more excitable than their counterparts in the matrix. Using patch clamp recordings in immature (postnatal days 12–32) tyrosine hydroxylase (TH)-GFP transgenic mice (to visualize presumptive striosomes), Miura and colleagues found that striosome SPNs have a higher input resistance and are more depolarized than those in the matrix (Miura et al., 2007). Similarly, using patch clamp recordings and CaIDAG-GEFI-GFP transgenic mice to visualize matrix neurons, Crittenden and colleagues found that not only are striosome SPNs more depolarized than those in the matrix, but they require less current injection to fire action potentials and fire at a higher frequency in response to similar current injections compared to matrix SPNs (Crittenden et al., 2017).

What is less clear is how such differences relate to dSPNs and iSPNs within and between compartments. Within the presumptive matrix, numerous lines of evidence suggest that iSPNs are more excitable than dSPNs. This includes measures of intrinsic somatic and dendritic excitability, action potential threshold and frequency of spontaneous excitatory synaptic inputs (Cepeda et al., 2008; Day et al., 2006; Gertler, Chan, & Surmeier, 2008; Kreitzer & Malenka, 2007). Using adult double transgenic mice to identify striosomes (Sepw1NP67-Cre mice, virally infected with cre-dependent tdTomato) and dSPNs (D1-eGFP mice), Smith and colleagues showed that striosome dSPNs fire more spikes in response to suprathreshold current injection than matrix dSPNs (Smith et al., 2016). This is consistent with preliminary data collected in our lab from Nr4a1-eGFP x drd1-tdTomato double transgenic mice (see our preprint: http://dx.doi.org/10.2139/ssrn.3263630). Interestingly, Smith and colleagues went on to show that this excitable phenotype extends to D1-receptor expressing exo-patch neurons as well (Smith et al., 2016). Whether or not iSPNs in striosomes are more excitable than iSPNs in the matrix, and if the same dSPN vs iSPN dichotomy observed in presumptively matrix recordings holds up within striosomes, remains to be determined.

Modulation of Synaptic Activity and Function in Striosome and Matrix Compartments

While differences in presynaptic inputs and postsynaptic excitability will shape compartment-specific activity and striatal output, it has become clear that neuromodulation also plays a major role. A growing number of studies (referenced below) have discovered that neuromodulation is not homogenous throughout the striatum, and can often be compartment-specific (Table 1). Such compartmental differences can be due to a variety of factors, some identified and some still mysterious, including differences in neuromodulator source, release and receptor expression. Below we will present key examples highlighting how differential neuromodulation may affect compartment-specific striatal circuit function and output.

Table 1:

Neuromodulation of Matrix and Striosome Compartments

Neurotransmitter /Receptor Matrix Compartmental Bias Striosomes References
•Multiphasic IPSCs in CINs > •Multiphasic IPSCs in CINs
Acetylcholine •Monophasic IPSCs in CINs < •Monophasic IPSCs in CINs Inoue et al., 2016
•CIN induced pause in SPN spiking < •CIN induced pause in SPN spiking Crittenden et al., 2017
Dopamine •relative c-Fos expression in response to amphetamine or cocaine < •relative c-Fos expression in response to amphetamine or cocaine Canales et al., 2000
Crittenden et al., 2017
Salinas et al., 2016
•Evoked DA release > •Evoked DA release
•Cocaine ↑ DA overflow < •Cocaine ↑ DA overflow
Glutamate/GABA •sIPSCs Frequency & Amplitude = •sIPSCs Frequency & Amplitude Smith et al., 2016 Prager et al., unpublished
•mEPSC Frequency & Amplitude = •mEPSC Frequency & Amplitude
•NMDA/AMPA Ratios (Proximal & distal spines) = •NMDA/AMPA Ratios (Proximal & distal spines)
μ-opioid receptor • MOR + DOR expression minimal < • MORs in dSPNs & iSPNs, DORs in iSPNs Miura et al., 2007
Smith et al., 2016
Banghart et al., 2015
•↓ EPSCs = •↓ EPSCs
• ENK (leu-ENK) has no effect on IPSCs in dSPNs & iSPNs < • ENK ↓ IPSCs (both striosomes & exo-patch neurons)
 ◆↓ IPSCs mediated by MORs and DORs
 ◆↓ IPSCs in dSPNs > iSPNs
 ◆DORs reduce collateral inhibition of dSPNs by iSPNs, subsequently disinhibiting dSPNs
Substance P •No change in DA release < •↑ DA release in striosome center Brimblecombe et al., 2015
•↓ DA release in striosome boundaries

Opioid Receptors

The striatum expresses three classes of opioid receptors: p (MORs), d (DORs) and k (KORs). Unlike KORs (the endogenous ligand of which is dynorphin), which are expressed homogenously throughout the striatum, MORs and DORs are enriched in striosomes and exo-patch neurons (Graybiel, 1990; Koizumi et al., 2013; Miura et al., 2007; Smith et al., 2016). Despite the striosomal-expression pattern of MORs and DORs, their endogenous ligand, enkephalin, is positioned to modulate synaptic transmission throughout the striatum. Presynaptically expressed MORs inhibit glutamatergic excitatory synaptic transmission to SPNs similarly in both striosome and matrix compartments (Miura et al., 2007). While it was initially presumed that this MOR-mediated inhibition occurred at corticostriatal synapses (Blomeley & Bracci, 2011; Miura et al., 2007), more recent studies have shown that thalamostriatal inputs are the targets of MORs, while corticostriatal inputs are attenuated by DORs (Atwood, Kupferschmidt, & Lovinger, 2014; Birdsong et al., 2019). Though opioid receptor-mediated attenuation of excitatory inputs to SPNs may be similar across compartments, attenuation of inhibitory inputs is not. A pioneering study by Miura and colleagues demonstrated that pharmacological activation of presynaptic MORs selectively attenuates GABA release and resulting postsynaptic inhibitory currents within striosomes, but not matrix (Miura et al., 2007). This preferential action of opioid receptor activation on inhibitory inputs has since been extended to include exo-patches (Smith et al., 2016). What was not clear from these studies was the local microcircuitry that was engaged. This issue was tackled in an elegant study by Banghart and colleagues, who used genetic and optical techniques (prodynorphin-EGFP mice to visualize striosomes, crossed with pathway-specific cre lines to target channelrhodopsin to dSPNs or iSPNs) to dissect the circuits involved (Banghart et al., 2015). While both dSPNs and iSPNs within striosomes express MORs, striosomal iSPNs contain functional DORs. Activation of DORs within striosomes attenuates iSPN-mediated collateral inhibition of dSPNs, promoting the disinhibition of striosome-associated targets such as the SNc (Banghart et al., 2015). The involvement of DORs (rather than MORs) in this phenomenon is at odds with earlier reports, but may reflect limitations in pharmacological tools (Banghart et al., 2015) or a developmental shift in receptor expression or function. It should be noted that disinhibition of striosomal output may also be achieved in opioid receptor-independent ways. For example, cannabinoid-1 receptors (CB1Rs), which attenuate presynaptic glutamate and GABA release in much the same way as opioid receptors do (Adermark, Talani, & Lovinger, 2009; Atwood et al., 2014), are preferentially expressed in SPN axon collaterals within striosomes in the dorsolateral striatum (Davis et al., 2018). As presynaptic CB1Rs are key determinants of endocannabinoid-mediated long term depression (LTD) within the striatum (Lovinger, 2010), it is tempting to speculate that the propensity for LTD at inhibitory SPN-SPN collateral connections or extrastriatal SPN axonal targets is augmented in striosomes.

Substance P

SP, which is released by dSPNs (Gerfen, 1992b), can also be used to distinguish striosomes and matrix as it is more highly expressed in the striosomes of adult rodents (Crittenden & Graybiel, 2011). SP is an endogenous ligand for neurokinin-1 (NK1) receptors, which are present on glutamatergic terminals within the striatum (Jakab & Goldman-Rakic, 1996) as well as several striatal interneuron populations (Chen, Cao, Liu, Ju, & Chan, 2003; Govindaiah, Wang, & Cox, 2010). Activity-dependent release of SP by SPN axon collaterals can potentiate responses to cortical inputs in neighboring SPNs, in a NK1 receptor-dependent manner (Blomeley, Kehoe, & Bracci, 2009). It remains to be determined if such facilitation is dominant in striosomes, as may be predicted by the expression profile of SP. NK1 receptor activation can also modulate dopamine release, though early descriptions in the striatum were inconsistent (Boix, Huston, & Schwarting, 1992; Starr, 1982; Tremblay, Kemel, Desban, Gauchy, & Glowinski, 1992). An elegant study by Brimblecombe and Cragg (2015) has recently shed light on this process, demonstrating that SP modulation of dopamine release in the striatum is not only compartment-specific but bidirectional (Brimblecombe & Cragg, 2015), a finding that likely explains the source of earlier confusion. Specifically, SP enhances striatal dopamine release in striosomes but not matrix. Moreover, the authors uncovered a border region between compartments (“peristriosomal boundaries”) where SP decreases dopamine release (Brimblecombe & Cragg, 2015). This finding not only clarified the role of SP in striatal circuit function, but described an additional functional region of striatal circuitry within the striosome/matrix organization, the significance of which is only beginning to be understood (Brimblecombe & Cragg, 2017).

Acetylcholine

CINs are the main source of ACh in the striatum. While CIN cell bodies tend to reside in the matrix and peristriosomal boundaries, and their neuropil is more extensive in the matrix, CINs are indeed present in both compartments and their processes do cross striosome-matrix boundaries (Abudukeyoumu et al., 2018; Bernacer, Prensa, & Gimenez-Amaya, 2007; Brimblecombe & Cragg, 2017; Crittenden, Lacey, Lee, Bowden, & Graybiel, 2014; Crittenden et al., 2017; Goldberg & Reynolds, 2011; Graybiel, Baughman, & Eckenstein, 1986; Inoue, Suzuki, Nishimura, & Miura, 2016; Jakab & Goldman-Rakic, 1996). Cholinergic signaling modulates myriad aspects of striatal circuit function (including cellular excitability, synaptic transmission and plasticity, dopamine release and circuit responses to salient cues), which are reviewed elsewhere (Abudukeyoumu et al., 2018; Gerfen & Surmeier, 2011; Goldberg & Reynolds, 2011; Plotkin & Goldberg, 2018), but we are only beginning to understand how this modulation occurs within the context of the striatum’s compartmental organization.

Fundamental to understanding compartmental differences in cholinergic signaling is the recent observation that CIN activity itself may be differentially modulated in striosomes vs matrix. CINs excite several classes of striatal GABAergic interneurons, via postsynaptic nicotinic acetylcholine receptors (nAChRs), which in turn send GABAergic projections back to CINs, forming an inhibitory feedback loop (Abudukeyoumu et al., 2018; Assous & Tepper, 2019). This feedback loop is considerably stronger in the matrix (Inoue et al., 2016). What is responsible for this compartmental difference? It is likely that the mechanism is rooted in the archetypal expression pattern of acetylcholinesterase, which is high in the matrix and low in striosomes (Graybiel & Ragsdale, 1978). Given that CINs release ACh in both striosomes and matrix (Crittenden et al., 2017; Inoue et al., 2016), it is reasonable to speculate that the dearth of acetylcholinesterase may amplify the lifespan of synaptically released ACh. Indeed, the frequency of nAChR-mediated GABAergic inputs to CINs is attenuated by both pharmacological application of ACh or inhibition of acetylcholinesterase (Inoue et al., 2016), perhaps reflecting higher basal ACh tone and desensitization of nAChRs in striosomes.

In addition to sending axon collaterals back to CINs, several populations of striatal interneurons also send GABAergic projections to SPNs, allowing CINs to modulate SPN activity in a multisynaptic nAChR- and GABA receptor- dependent manner (Assous & Tepper, 2019; English et al., 2011; Faust, Assous, Tepper, & Koos, 2016; Luo, Janssen, Partridge, & Vicini, 2013; Nelson et al., 2014). Recent work suggests that a functional multisynaptic connection from CINs to SPNs is present in both compartments, and it may be stronger in striosomes (Crittenden et al., 2017). Specifically, using CalDAG-GEFI-EGFP mice to visualize matrix neurons Crittenden and colleagues demonstrated that optogenetic stimulation of CINs disrupt the firing patterns of SPNs in ex vivo striatal slices in a nAChR-dependent way, though the dependence upon GABA remains unclear. Furthermore, repeated in vivo administration of D-amphetamine, which induces behavioral stereotypies and preferential cFos induction in striosomes relative to reduced activation in matrix, abolishes the ability of CINs to disrupt SPN firing (Canales & Graybiel, 2000; Crittenden et al., 2017). This, along with observations that 1) destruction of striatal CINs (and somatostatinergic interneurons) prevents the above drug-induced striosome/matrix pattern of cFos induction, 2) pharmacological blockade of striatal cholinergic signaling increases drug-induced stereotypies and 3) globally elevating acetylcholine release also exacerbates drug-induced stereotypies (Aliane, Perez, Bohren, Deniau, & Kemel, 2011; Crittenden et al., 2014; Janickova, Prado, Prado, El Mestikawy, & Bernard, 2017; Saka, Iadarola, Fitzgerald, & Graybiel, 2002; see also the preprint by Crittenden et al., deposited in bioRxiv on July 22, 2019 https://www.biorxiv.org/content/10.1101/709246v1), suggests that a precise balance of striatal cholinergic signaling may be required to shape striosome-linked behaviors and prevent pathological stereotypy.

Dopamine

DA modulation of striatal circuit function plays an integral role in shaping behavioral output (Cox & Witten, 2019; Gerfen & Surmeier, 2011; Plotkin & Goldberg, 2018). Canonically, elevations in dopamine will promote activity of dSPNs and suppress activity of iSPNs, ultimately favoring disinhibition of the thalamus (Albin et al., 1989; Alexander & Crutcher, 1990; Gerfen & Surmeier, 2011). Although all areas of the striatum receive dense dopaminergic innervation, the source of dopaminergic fibers varies by region and compartment. The dorsal tier of the SNc and the ventral tegmental area preferentially supply DA to dorsal and ventral striatal regions, respectively, with the primary targets being in the matrix. The primary source of DA inputs to striosomes, however, is the ventral tier of the SNc (Gerfen, Herkenham, & Thibault, 1987; Haber, 2014; Matsuda et al., 2009; Prensa & Parent, 2001). This heterogeneous innervation pattern, along with compartmental gradients of other neuromodulators that locally regulate DA release (Brimblecombe & Cragg, 2017), set a plausible framework for compartmentally-dissociated DA signaling. Indeed, the pioneering study by Canales and Graybiel (2000) mentioned above demonstrated that repeated activation of the dopaminergic system induces preferential immediate early gene expression in striosomes relative to decreased induction in the matrix (Canales & Graybiel, 2000).

As described above, SP modulation of striatal DA release is spatially heterogeneous and compartment-specific (Brimblecombe & Cragg, 2015). Recent work by Salinas and colleagues (2016) has demonstrated that evoked DA release, and its modulation by cocaine, is also compartment and region specific. Using acute striatal slices from Nr4a1-GFP mice to visualize striosomes (Davis & Puhl, 2011), the authors demonstrated that electrically evoked DA release is lower in striosomes than the surrounding matrix in the dorsal striatum, and this relationship is reversed in the ventral striatum (Salinas, Davis, Lovinger, & Mateo, 2016). Furthermore, cocaine augmentation of DA release is greater in striosomes than matrix in the dorsal striatum, an observation that can only be partially explained by differences in dopamine transporter inhibition. Importantly, although activation of presynaptic nAChRs promotes local DA release (Threlfell et al., 2012), this mechanism appears to be similar in striosomes and matrix and does not account for the observed differences in evoked release (Salinas et al., 2016). Why compartmental differences in acetylcholinesterase activity correlate with nAChR-mediated modulation of GABAergic signaling (Inoue et al., 2016) but not DA release (Salinas et al., 2016) is unclear, but may reflect differences in basal CIN activity and ACh levels achieved by the unique experimental slice conditions.

While the regulation of DA release is clearly different in striosomes and matrix, it remains to be determined if postsynaptic DA signaling is similar in SPNs of each compartment. Specifically, although dSPNs and iSPNs in striosomes and matrix express comparable DA receptors, the consequences of DA receptor activation are ultimately determined by additional factors, including the functional state of the neuron and the ion channels it possesses (Cepeda, Colwell, Itri, Chandler, & Levine, 1998; Gerfen & Surmeier, 2011; Liu et al., 2004). As described above, SPNs do exhibit compartment-specific physiological properties, raising the caveat that functional modulation by DA may differ as well. Indeed, preliminary data from our laboratory suggest that that this may be the case (https://dx.doi.org/10.2139/ssrn.3263630).

Summary and going forward

The complexity of striatal compartmentalization and its role in shaping behavior are only starting to become clear. While decades of research have led to an overall model of basal ganglia function where limbic and sensorimotor loops are compartmentalized to guide unique aspects of behavior, newly developed tools are opening the door to test fundamental hypotheses in functioning circuits and living animals. Of keen interest to public health will be using these tools to follow old clues about the pathologies underlying disease states. For example, the correlation between striosome activation and repetitive behaviors has overt implications for conditions such as obsessive-compulsive disorder (Canales & Graybiel, 2000) - can dissection of the mechanism underlying drug-induced engagement of striosomes shed light on the underlying cause of this disorder? Pathological reports and animal models suggest that SNc neurons projecting to striosomes vs matrix may be differentially vulnerable in Parkinson’s disease (Gibb & Lees, 1991; Moratalla et al., 1992) - does this play a role in disease progression, and are there compartment-specific responses to DA replacement strategies that need to be identified and considered? One of the earliest pathologies in Huntington’s disease is the loss or alteration of neurons within striosomes (Hedreen & Folstein, 1995; Menalled et al., 2002). Interestingly, choreic symptoms of Huntington’s disease are associated with elevated dopamine, and dopamine blockers such as tetrabenazine are used to treat motor symptoms (Zuccato, Valenza, & Cattaneo, 2010). Might the pathological dopamine fluctuations seen in early stages of Huntington’s disease be the result of dysfunctional striosomal inhibition of SNc neurons? As technology continues to advance, so too will our ability to address such questions.

SIGNIFICANCE STATEMENT.

The way in which striatal compartmental organization influences complex behavioral patterns remains elusive. With modern technologies, the functional differences between striosome and matrix compartments are becoming clear. In this review, we summarize the anatomical and functional similarities and differences between the compartments and discuss how compartment-specific circuit function is shaped by neuromodulation. We also point out how technological advances have led to changes in our understanding of striatal compartmental organization and its influence on behavior.

Acknowledgments

Funding

This work was supported by NS104089 and a NARSAD Young Investigator Award to JLP.

Footnotes

Conflict of Interest Statement

The authors declare no known conflicts of interest

References

  1. Abudukeyoumu N, Hernandez-Flores T, Garcia-Munoz M, & Arbuthnott GW (2018). Cholinergic modulation of striatal microcircuits. Eur J Neurosci. doi: 10.1111/ejn.13949 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adermark L, Talani G, & Lovinger DM (2009). Endocannabinoid-dependent plasticity at GABAergic and glutamatergic synapses in the striatum is regulated by synaptic activity. Eur J Neurosci, 29(1), 32–41. doi: 10.1111/j.1460-9568.2008.06551.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Albin RL, Young AB, & Penney JB (1989). The functional anatomy of basal ganglia disorders. Trends Neurosci, 12(10), 366–375. [DOI] [PubMed] [Google Scholar]
  4. Alexander GE, & Crutcher MD (1990). Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci, 13(7), 266–271. [DOI] [PubMed] [Google Scholar]
  5. Aliane V, Perez S, Bohren Y, Deniau JM, & Kemel ML (2011). Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies. Brain, 134(Pt 1), 110–118. doi: 10.1093/brain/awq285 [DOI] [PubMed] [Google Scholar]
  6. Amemori K, Gibb LG, & Graybiel AM (2011). Shifting responsibly: the importance of striatal modularity to reinforcement learning in uncertain environments. Front Hum Neurosci, 5, 47. doi: 10.3389/fnhum.2011.00047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Assous M, & Tepper JM (2019). Excitatory extrinsic afferents to striatal interneurons and interactions with striatal microcircuitry. Eur J Neurosci, 49(5), 593–603. doi: 10.1111/ejn.13881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Atwood BK, Kupferschmidt DA, & Lovinger DM (2014). Opioids induce dissociable forms of long-term depression of excitatory inputs to the dorsal striatum. Nat Neurosci, 17(4), 540–548. doi: 10.1038/nn.3652 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Banghart MR, Neufeld SQ, Wong NC, & Sabatini BL (2015). Enkephalin Disinhibits Mu Opioid Receptor-Rich Striatal Patches via Delta Opioid Receptors. Neuron, 88(6), 1227–1239. doi: 10.1016/j.neuron.2015.11.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bernacer J, Prensa L, & Gimenez-Amaya JM (2007). Cholinergic interneurons are differentially distributed in the human striatum. PLoS One, 2(11), e1174. doi: 10.1371/journal.pone.0001174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Bernacer J, Prensa L, & Gimenez-Amaya JM (2012). Distribution of GABAergic interneurons and dopaminergic cells in the functional territories of the human striatum. PLoS One, 7(1), e30504. doi: 10.1371/journal.pone.0030504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Birdsong WT, Jongbloets BC, Engeln KA, Wang D, Scherrer G, & Mao T (2019). Synapse-specific opioid modulation of thalamo-cortico-striatal circuits. Elife, 8. doi: 10.7554/eLife.45146 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bloem B, Huda R, Sur M, & Graybiel AM (2017). Two-photon imaging in mice shows striosomes and matrix have overlapping but differential reinforcement-related responses. Elife, 6. doi: 10.7554/eLife.32353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Blomeley CP, & Bracci E (2011). Opioidergic interactions between striatal projection neurons. J Neurosci, 31(38), 13346–13356. doi: 10.1523/JNEUROSCI.1775-11.2011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Blomeley CP, Kehoe LA, & Bracci E (2009). Substance P mediates excitatory interactions between striatal projection neurons. J Neurosci, 29(15), 4953–4963. doi: 10.1523/JNEUROSCI.6020-08.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Boix F, Huston JP, & Schwarting RK (1992). The C-terminal fragment of substance P enhances dopamine release in nucleus accumbens but not in neostriatum in freely moving rats. Brain Res, 592(1–2), 181–186. [DOI] [PubMed] [Google Scholar]
  17. Bolam JP, Hanley JJ, Booth PA, & Bevan MD (2000). Synaptic organisation of the basal ganglia. J Anat, 196 (Pt 4), 527–542. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Bolam JP, Izzo PN, & Graybiel AM (1988). Cellular substrate of the histochemically defined striosome/matrix system of the caudate nucleus: a combined Golgi and immunocytochemical study in cat and ferret. Neuroscience, 24(3), 853–875. [DOI] [PubMed] [Google Scholar]
  19. Brimblecombe KR, & Cragg SJ (2015). Substance P Weights Striatal Dopamine Transmission Differently within the Striosome-Matrix Axis. J Neurosci, 35(24), 9017–9023. doi: 10.1523/JNEUROSCI.0870-15.2015 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Brimblecombe KR, & Cragg SJ (2017). The Striosome and Matrix Compartments of the Striatum: A Path through the Labyrinth from Neurochemistry toward Function. ACS Chem Neurosci, 8(2), 235–242. doi: 10.1021/acschemneuro.6b00333 [DOI] [PubMed] [Google Scholar]
  21. Brimblecombe KR, Threlfell S, Dautan D, Kosillo P, Mena-Segovia J, & Cragg SJ (2018). Targeted Activation of Cholinergic Interneurons Accounts for the Modulation of Dopamine by Striatal Nicotinic Receptors. eNeuro, 5(5). doi: 10.1523/ENEURO.0397-17.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Canales JJ (2005). Stimulant-induced adaptations in neostriatal matrix and striosome systems: transiting from instrumental responding to habitual behavior in drug addiction. Neurobiol Learn Mem, 83(2), 93–103. doi: 10.1016/j.nlm.2004.10.006 [DOI] [PubMed] [Google Scholar]
  23. Canales JJ, & Graybiel AM (2000). A measure of striatal function predicts motor stereotypy. Nat Neurosci, 3(4), 377–383. doi: 10.1038/73949 [DOI] [PubMed] [Google Scholar]
  24. Cazorla M, de Carvalho FD, Chohan MO, Shegda M, Chuhma N, Rayport S, … Kellendonk C (2014). Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron, 81(1), 153–164. doi: 10.1016/j.neuron.2013.10.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Cepeda C, Andre VM, Yamazaki I, Wu N, Kleiman-Weiner M, & Levine MS (2008). Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons. Eur J Neurosci, 27(3), 671–682. doi: 10.1111/j.1460-9568.2008.06038.x [DOI] [PubMed] [Google Scholar]
  26. Cepeda C, Colwell CS, Itri JN, Chandler SH, & Levine MS (1998). Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. J Neurophysiol, 79(1), 82–94. doi: 10.1152/jn.1998.79.1.82 [DOI] [PubMed] [Google Scholar]
  27. Chen LW, Cao R, Liu HL, Ju G, & Chan YS (2003). The striatal GABA-ergic neurons expressing substance P receptors in the basal ganglia of mice. Neuroscience, 119(4), 919–925. doi: 10.1016/s0306-4522(03)00223-9 [DOI] [PubMed] [Google Scholar]
  28. Cowan RL, Wilson CJ, Emson PC, & Heizmann CW (1990). Parvalbumin-containing GABAergic interneurons in the rat neostriatum. J Comp Neurol, 302(2), 197–205. doi: 10.1002/cne.903020202 [DOI] [PubMed] [Google Scholar]
  29. Cox J, & Witten IB (2019). Striatal circuits for reward learning and decision-making. Nat Rev Neurosci, 20(8), 482–494. doi: 10.1038/s41583-019-0189-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Crittenden JR, & Graybiel AM (2011). Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front Neuroanat, 5, 59. doi: 10.3389/fnana.2011.00059 [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Crittenden JR, Lacey CJ, Lee T, Bowden HA, & Graybiel AM (2014). Severe drug-induced repetitive behaviors and striatal overexpression of VAChT in ChAT-ChR2-EYFP BAC transgenic mice. Front Neural Circuits, 8, 57. doi: 10.3389/fncir.2014.00057 [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Crittenden JR, Lacey CJ, Weng FJ, Garrison CE, Gibson DJ, Lin Y, & Graybiel AM (2017). Striatal Cholinergic Interneurons Modulate Spike-Timing in Striosomes and Matrix by an Amphetamine-Sensitive Mechanism. Front Neuroanat, 11, 20. doi: 10.3389/fnana.2017.00020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Crittenden JR, Tillberg PW, Riad MH, Shima Y, Gerfen CR, Curry J, … Graybiel AM (2016). Striosome-dendron bouquets highlight a unique striatonigral circuit targeting dopamine- containing neurons. Proc Natl Acad Sci U S A, 113(40), 11318–11323. doi: 10.1073/pnas.1613337113 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Davis MI, Crittenden JR, Feng AY, Kupferschmidt DA, Naydenov A, Stella N, … Lovinger DM (2018). The cannabinoid-1 receptor is abundantly expressed in striatal striosomes and striosome-dendron bouquets of the substantia nigra. PLoS One, 13(2), e0191436. doi: 10.1371/journal.pone.0191436 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Davis MI, & Puhl HL 3rd. (2011). Nr4a1-eGFP is a marker of striosome-matrix architecture, development and activity in the extended striatum. PLoS One, 6(1), e16619. doi: 10.1371/journal.pone.0016619 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF, … Surmeier DJ (2006). Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci, 9(2), 251–259. doi: 10.1038/nn1632 [DOI] [PubMed] [Google Scholar]
  37. Desban M, Kemel ML, Glowinski J, & Gauchy C (1993). Spatial organization of patch and matrix compartments in the rat striatum. Neuroscience, 57(3), 661–671. [DOI] [PubMed] [Google Scholar]
  38. Donoghue JP, & Herkenham M (1986). Neostriatal projections from individual cortical fields conform to histochemically distinct striatal compartments in the rat. Brain Res, 365(2), 397–403. [DOI] [PubMed] [Google Scholar]
  39. Eblen F, & Graybiel AM (1995). Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey. J Neurosci, 15(9), 5999–6013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Ebrahimi A, Pochet R, & Roger M (1992). Topographical organization of the projections from physiologically identified areas of the motor cortex to the striatum in the rat. Neurosci Res, 14(1), 39–60. [DOI] [PubMed] [Google Scholar]
  41. English DF, Ibanez-Sandoval O, Stark E, Tecuapetla F, Buzsaki G, Deisseroth K, … Koos T (2011). GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons. Nat Neurosci, 15(1), 123–130. doi: 10.1038/nn.2984 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Faust TW, Assous M, Tepper JM, & Koos T (2016). Neostriatal GABAergic Interneurons Mediate Cholinergic Inhibition of Spiny Projection Neurons. J Neurosci, 36(36), 9505–9511. doi: 10.1523/JNEUROSCI.0466-16.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Fishell G, & van der Kooy D (1987). Pattern formation in the striatum: developmental changes in the distribution of striatonigral neurons. J Neurosci, 7(7), 1969–1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Flaherty AW, & Graybiel AM (1994). Input-output organization of the sensorimotor striatum in the squirrel monkey. J Neurosci, 14(2), 599–610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Friedman A, Homma D, Bloem B, Gibb LG, Amemori KI, Hu D, … Graybiel AM (2017). Chronic Stress Alters Striosome-Circuit Dynamics, Leading to Aberrant Decision-Making. Cell, 171(5), 1191–1205 e1128. doi: 10.1016/j.cell.2017.10.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Friedman A, Homma D, Gibb LG, Amemori K, Rubin SJ, Hood AS, … Graybiel AM (2015). A Corticostriatal Path Targeting Striosomes Controls Decision-Making under Conflict. Cell, 161(6), 1320–1333. doi: 10.1016/j.cell.2015.04.049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Fujiyama F, Sohn J, Nakano T, Furuta T, Nakamura KC, Matsuda W, & Kaneko T (2011). Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci, 33(4), 668–677. doi: 10.1111/j.1460-9568.2010.07564.x [DOI] [PubMed] [Google Scholar]
  48. Gerfen CR (1984). The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature, 311(5985), 461–464. [DOI] [PubMed] [Google Scholar]
  49. Gerfen CR (1985). The neostriatal mosaic. I. Compartmental organization of projections from the striatum to the substantia nigra in the rat. J Comp Neurol, 236(4), 454–476. doi: 10.1002/cne.902360404 [DOI] [PubMed] [Google Scholar]
  50. Gerfen CR (1989). The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. Science, 246(4928), 385–388. [DOI] [PubMed] [Google Scholar]
  51. Gerfen CR (1992a). The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci, 15(4), 133–139. [DOI] [PubMed] [Google Scholar]
  52. Gerfen CR (1992b). The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. Annu Rev Neurosci, 15, 285–320. doi: 10.1146/annurev.ne.15.030192.001441 [DOI] [PubMed] [Google Scholar]
  53. Gerfen CR (2006). Indirect-pathway neurons lose their spines in Parkinson disease. Nat Neurosci, 9(2), 157–158. doi: 10.1038/nn0206-157 [DOI] [PubMed] [Google Scholar]
  54. Gerfen CR, Baimbridge KG, & Miller JJ (1985). The neostriatal mosaic: compartmental distribution of calcium-binding protein and parvalbumin in the basal ganglia of the rat and monkey. Proc Natl Acad Sci U S A, 82(24), 8780–8784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr., & Sibley DR (1990). D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science, 250(4986), 1429–1432. [DOI] [PubMed] [Google Scholar]
  56. Gerfen CR, Herkenham M, & Thibault J (1987). The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci, 7(12), 3915–3934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Gerfen CR, Paletzki R, & Heintz N (2013). GENSAT BAC cre-recombinase driver lines to study the functional organization of cerebral cortical and basal ganglia circuits. Neuron, 80(6), 1368–1383. doi: 10.1016/j.neuron.2013.10.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Gerfen CR, & Surmeier DJ (2011). Modulation of striatal projection systems by dopamine. Annu Rev Neurosci, 34, 441–466. doi: 10.1146/annurev-neuro-061010-113641 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Gerfen CR, & Wilson CJ (1996). The Basal Ganglia In Hokfelt T & Swanson LW (Eds.), Handbook of Chemical Neuroanatomy (pp. 365–462): Elsevier. [Google Scholar]
  60. Gerfen CR, & Young WS (1988). Distribution of striatonigral and striatopallidal peptidergic neurons in both patch and matrix compartments: an in situ hybridization histochemistry and fluorescent retrograde tracing study. Brain Res, 460, 161–167. doi: 10.1016/0006-8993(88)91217-6 [DOI] [PubMed] [Google Scholar]
  61. Gertler TS, Chan CS, & Surmeier DJ (2008). Dichotomous anatomical properties of adult striatal medium spiny neurons. J Neurosci, 28(43), 10814–10824. doi: 10.1523/JNEUROSCI.2660-08.2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Gibb WR, & Lees AJ (1991). Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease. J Neurol Neurosurg Psychiatry, 54(5), 388–396. doi: 10.1136/jnnp.54.5.388 [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Goldberg JA, & Reynolds JN (2011). Spontaneous firing and evoked pauses in the tonically active cholinergic interneurons of the striatum. Neuroscience, 198, 27–43. doi: 10.1016/j.neuroscience.2011.08.067 [DOI] [PubMed] [Google Scholar]
  64. Gong S, Zheng C, Doughty ML, Losos K, Didkovsky N, Schambra UB, … Heintz N (2003). A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature, 425(6961), 917–925. doi: 10.1038/nature02033 [DOI] [PubMed] [Google Scholar]
  65. Govindaiah G, Wang Y, & Cox CL (2010). Substance P selectively modulates GABA(A) receptor-mediated synaptic transmission in striatal cholinergic interneurons. Neuropharmacology, 58(2), 413–422. doi: 10.1016/j.neuropharm.2009.09.011 [DOI] [PubMed] [Google Scholar]
  66. Graybiel AM (1984). Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuroscience, 13(4), 1157–1187. [DOI] [PubMed] [Google Scholar]
  67. Graybiel AM (1990). Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci, 13(7), 244–254. [DOI] [PubMed] [Google Scholar]
  68. Graybiel AM (2008). Habits, rituals, and the evaluative brain. Annu Rev Neurosci, 31, 359–387. doi: 10.1146/annurev.neuro.29.051605.112851 [DOI] [PubMed] [Google Scholar]
  69. Graybiel AM, Baughman RW, & Eckenstein F (1986). Cholinergic neuropil of the striatum observes striosomal boundaries. Nature, 323(6089), 625–627. doi: 10.1038/323625a0 [DOI] [PubMed] [Google Scholar]
  70. Graybiel AM, & Hickey TL (1982). Chemospecificity of ontogenetic units in the striatum: demonstration by combining [3H]thymidine neuronography and histochemical staining. Proc Natl Acad Sci U S A, 79(1), 198–202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Graybiel AM, Pickel VM, Joh TH, Reis DJ, & Ragsdale CW Jr. (1981). Direct demonstration of a correspondence between the dopamine islands and acetylcholinesterase patches in the developing striatum. Proc Natl Acad Sci U S A, 78(9), 5871–5875. doi: 10.1073/pnas.78.9.5871 [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Graybiel AM, & Ragsdale CW Jr. (1978). Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc Natl Acad Sci U S A, 75(11), 5723–5726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Guttenberg ND, Klop H, Minami M, Satoh M, & Voorn P (1996). Co-localization of mu opioid receptor is greater with dynorphin than enkephalin in rat striatum. Neuroreport, 7(13), 2119–2124. [DOI] [PubMed] [Google Scholar]
  74. Haber SN (2014). The place of dopamine in the cortico-basal ganglia circuit. Neuroscience, 282, 248–257. doi: 10.1016/j.neuroscience.2014.10.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Hagimoto K, Takami S, Murakami F, & Tanabe Y (2017). Distinct migratory behaviors of striosome and matrix cells underlying the mosaic formation in the developing striatum. J Comp Neurol, 525(4), 794–817. doi: 10.1002/cne.24096 [DOI] [PubMed] [Google Scholar]
  76. Hedreen JC, & Folstein SE (1995). Early loss of neostriatal striosome neurons in Huntington’s disease. J Neuropathol Exp Neurol, 54(1), 105–120. doi: 10.1097/00005072-199501000-00013 [DOI] [PubMed] [Google Scholar]
  77. Herkenham M, Edley SM, & Stuart J (1984). Cell clusters in the nucleus accumbens of the rat, and the mosaic relationship of opiate receptors, acetylcholinesterase and subcortical afferent terminations. Neuroscience, 11(3), 561–593. [DOI] [PubMed] [Google Scholar]
  78. Herkenham M, & Pert CB (1981). Mosaic distribution of opiate receptors, parafascicular projections and acetylcholinesterase in rat striatum. Nature, 291(5814), 415–418. [DOI] [PubMed] [Google Scholar]
  79. Hong S, Amemori S, Chung E, Gibson DJ, Amemori KI, & Graybiel AM (2019). Predominant Striatal Input to the Lateral Habenula in Macaques Comes from Striosomes. Curr Biol, 29(1), 5161 e55. doi: 10.1016/j.cub.2018.11.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Hong S, & Hikosaka O (2013). Diverse sources of reward value signals in the basal ganglia nuclei transmitted to the lateral habenula in the monkey. Front Hum Neurosci, 7, 778. doi: 10.3389/fnhum.2013.00778 [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Inoue R, Suzuki T, Nishimura K, & Miura M (2016). Nicotinic acetylcholine receptor-mediated GABAergic inputs to cholinergic interneurons in the striosomes and the matrix compartments of the mouse striatum. Neuropharmacology, 105, 318–328. doi: 10.1016/j.neuropharm.2016.01.029 [DOI] [PubMed] [Google Scholar]
  82. Jakab RL, & Goldman-Rakic P (1996). Presynaptic and postsynaptic subcellular localization of substance P receptor immunoreactivity in the neostriatum of the rat and rhesus monkey (Macaca mulatta). J Comp Neurol, 369(1), 125–136. doi: [DOI] [PubMed] [Google Scholar]
  83. Janickova H, Prado VF, Prado MAM, El Mestikawy S, & Bernard V (2017). Vesicular acetylcholine transporter (VAChT) over-expression induces major modifications of striatal cholinergic interneuron morphology and function. J Neurochem, 142(6), 857–875. doi: 10.1111/jnc.14105 [DOI] [PubMed] [Google Scholar]
  84. Jimenez-Castellanos J, & Graybiel AM (1987). Subdivisions of the primate substantia nigra pars compacta detected by acetylcholinesterase histochemisty. Brain Res, 437(2), 349–354. [DOI] [PubMed] [Google Scholar]
  85. Jimenez-Castellanos J, & Graybiel AM (1989). Compartmental origins of striatal efferent projections in the cat. Neuroscience, 32(2), 297–321. [DOI] [PubMed] [Google Scholar]
  86. Jin X, & Costa RM (2015). Shaping action sequences in basal ganglia circuits. Curr Opin Neurobiol, 33, 188–196. doi: 10.1016/j.conb.2015.06.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Johnston JG, Gerfen CR, Haber SN, & van der Kooy D (1990). Mechanisms of striatal pattern formation: conservation of mammalian compartmentalization. Brain Res Dev Brain Res, 57(1), 93–102. [DOI] [PubMed] [Google Scholar]
  88. Kawaguchi Y, Wilson CJ, & Emson PC (1989). Intracellular recording of identified neostriatal patch and matrix spiny cells in a slice preparation preserving cortical inputs. J Neurophysiol, 62(5), 1052–1068. doi: 10.1152/jn.1989.62.5.1052 [DOI] [PubMed] [Google Scholar]
  89. Kawaguchi Y, Wilson CJ, & Emson PC (1990). Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci, 10(10), 3421–3438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Kelly SM, Raudales R, He M, Lee JH, Kim Y, Gibb LG, … Huang ZJ (2018). Radial Glial Lineage Progression and Differential Intermediate Progenitor Amplification Underlie Striatal Compartments and Circuit Organization. Neuron, 99(2), 345–361 e344. doi: 10.1016/j.neuron.2018.06.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  91. Kincaid AE, & Wilson CJ (1996). Corticostriatal innervation of the patch and matrix in the rat neostriatum. J Comp Neurol, 374(4), 578–592. doi: [DOI] [PubMed] [Google Scholar]
  92. Koizumi H, Morigaki R, Okita S, Nagahiro S, Kaji R, Nakagawa M, & Goto S (2013). Response of striosomal opioid signaling to dopamine depletion in 6-hydroxydopamine-lesioned rat model of Parkinson’s disease: a potential compensatory role. Front Cell Neurosci, 7, 74. doi: 10.3389/fncel.2013.00074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  93. Kravitz AV, Tye LD, & Kreitzer AC (2012). Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci, 15(6), 816–818. doi: 10.1038/nn.3100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Kreitzer AC (2009). Physiology and pharmacology of striatal neurons. Annu Rev Neurosci, 32, 127–147. doi: 10.1146/annurev.neuro.051508.135422 [DOI] [PubMed] [Google Scholar]
  95. Kreitzer AC, & Malenka RC (2007). Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson’s disease models. Nature, 445(7128), 643–647. doi: 10.1038/nature05506 [DOI] [PubMed] [Google Scholar]
  96. Kubota Y, & Kawaguchi Y (1993). Spatial distributions of chemically identified intrinsic neurons in relation to patch and matrix compartments of rat neostriatum. J Comp Neurol, 332(4), 499–513. doi: 10.1002/cne.903320409 [DOI] [PubMed] [Google Scholar]
  97. Le Moine C, Normand E, & Bloch B (1991). Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc Natl Acad Sci U S A, 88(10), 4205–4209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  98. Levesque M, Charara A, Gagnon S, Parent A, & Deschenes M (1996). Corticostriatal projections from layer V cells in rat are collaterals of long-range corticofugal axons. Brain Res, 709(2), 311–315. [DOI] [PubMed] [Google Scholar]
  99. Levesque M, & Parent A (2005). The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proc Natl Acad Sci U S A, 102(33), 11888–11893. doi: 10.1073/pnas.0502710102 [DOI] [PMC free article] [PubMed] [Google Scholar]
  100. Liu JC, DeFazio RA, Espinosa-Jeffrey A, Cepeda C, de Vellis J, & Levine MS (2004). Calcium modulates dopamine potentiation of N-methyl-D-aspartate responses: electrophysiological and imaging evidence. J Neurosci Res, 76(3), 315–322. doi: 10.1002/jnr.20079 [DOI] [PubMed] [Google Scholar]
  101. Lopez-Huerta VG, Nakano Y, Bausenwein J, Jaidar O, Lazarus M, Cherassse Y, … Arbuthnott G (2016). The neostriatum: two entities, one structure? Brain Struct Funct, 221(3), 1737–1749. doi: 10.1007/s00429-015-1000-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  102. Lovinger DM (2010). Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology, 58(7), 951–961. doi: 10.1016/j.neuropharm.2010.01.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  103. Luo R, Janssen MJ, Partridge JG, & Vicini S (2013). Direct and GABA-mediated indirect effects of nicotinic ACh receptor agonists on striatal neurones. J Physiol, 591(1), 203–217. doi: 10.1113/jphysiol.2012.241786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  104. Matamales M, Gotz J, & Bertran-Gonzalez J (2016). Quantitative Imaging of Cholinergic Interneurons Reveals a Distinctive Spatial Organization and a Functional Gradient across the Mouse Striatum. PLoS One, 11(6), e0157682. doi: 10.1371/journal.pone.0157682 [DOI] [PMC free article] [PubMed] [Google Scholar]
  105. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, & Kaneko T (2009). Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci, 29(2), 444–453. doi: 10.1523/JNEUROSCI.4029-08.2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  106. Menalled LB, Sison JD, Wu Y, Olivieri M, Li XJ, Li H, … Chesselet MF (2002). Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington’s disease knock-in mice. J Neurosci, 22(18), 8266–8276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  107. Miura M, Saino-Saito S, Masuda M, Kobayashi K, & Aosaki T (2007). Compartment-specific modulation of GABAergic synaptic transmission by mu-opioid receptor in the mouse striatum with green fluorescent protein-expressing dopamine islands. J Neurosci, 27(36), 9721–9728. doi: 10.1523/JNEUROSCI.2993-07.2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  108. Miyamoto Y, Katayama S, Shigematsu N, Nishi A, & Fukuda T (2018). Striosome-based map of the mouse striatum that is conformable to both cortical afferent topography and uneven distributions of dopamine D1 and D2 receptor-expressing cells. Brain Struct Funct, 223(9), 4275–4291. doi: 10.1007/s00429-018-1749-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  109. Moon Edley S, & Herkenham M (1984). Comparative development of striatal opiate receptors and dopamine revealed by autoradiography and histofluorescence. Brain Res, 305(1), 27–42. [DOI] [PubMed] [Google Scholar]
  110. Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW, & Graybiel AM (1992). Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A, 89(9), 3859–3863. doi: 10.1073/pnas.89.9.3859 [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Morigaki R, & Goto S (2016). Putaminal Mosaic Visualized by Tyrosine Hydroxylase Immunohistochemistry in the Human Neostriatum. Front Neuroanat, 10, 34. doi: 10.3389/fnana.2016.00034 [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Nakamura K, Hioki H, Fujiyama F, & Kaneko T (2005). Postnatal changes of vesicular glutamate transporter (VGluT)1 and VGluT2 immunoreactivities and their colocalization in the mouse forebrain. J Comp Neurol, 492(3), 263–288. doi: 10.1002/cne.20705 [DOI] [PubMed] [Google Scholar]
  113. Nelson AB, Hammack N, Yang CF, Shah NM, Seal RP, & Kreitzer AC (2014). Striatal cholinergic interneurons Drive GABA release from dopamine terminals. Neuron, 82(1), 63–70. doi: 10.1016/j.neuron.2014.01.023 [DOI] [PMC free article] [PubMed] [Google Scholar]
  114. Newman H, Liu FC, & Graybiel AM (2015). Dynamic ordering of early generated striatal cells destined to form the striosomal compartment of the striatum. J Comp Neurol, 523(6), 943–962. doi: 10.1002/cne.23725 [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Olson L, Seiger A, & Fuxe K (1972). Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res, 44(1), 283–288. [DOI] [PubMed] [Google Scholar]
  116. Onn SP, Berger TW, & Grace AA (1994). Identification and characterization of striatal cell subtypes using in vivo intracellular recording in rats: I. Basic physiology and response to corticostriatal fiber stimulation. Synapse, 16(3), 161–180. doi: 10.1002/syn.890160302 [DOI] [PubMed] [Google Scholar]
  117. Penny GR, Wilson CJ, & Kitai ST (1988). Relationship of the axonal and dendritic geometry of spiny projection neurons to the compartmental organization of the neostriatum. J Comp Neurol, 269(2), 275–289. doi: 10.1002/cne.902690211 [DOI] [PubMed] [Google Scholar]
  118. Pert CB, Kuhar MJ, & Snyder SH (1976). Opiate receptor: autoradiographic localization in rat brain. Proc Natl Acad Sci U S A, 73(10), 3729–3733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  119. Plotkin JL, & Goldberg JA (2018). Thinking Outside the Box (and Arrow): Current Themes in Striatal Dysfunction in Movement Disorders. Neuroscientist, 1073858418807887. doi: 10.1177/1073858418807887 [DOI] [PMC free article] [PubMed] [Google Scholar]
  120. Prensa L, & Parent A (2001). The nigrostriatal pathway in the rat: A single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J Neurosci, 21(18), 7247–7260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Ragsdale CW Jr., & Graybiel AM (1988). Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat. J Comp Neurol, 269(4), 506–522. doi: 10.1002/cne.902690404 [DOI] [PubMed] [Google Scholar]
  122. Ragsdale CW Jr., & Graybiel AM (1990). A simple ordering of neocortical areas established by the compartmental organization of their striatal projections. Proc Natl Acad Sci U S A, 87(16), 6196–6199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Rajakumar N, Elisevich K, & Flumerfelt BA (1993). Compartmental origin of the striato-entopeduncular projection in the rat. J Comp Neurol, 331(2), 286–296. doi: 10.1002/cne.903310210 [DOI] [PubMed] [Google Scholar]
  124. Rushlow W, Naus CC, & Flumerfelt BA (1996). Somatostatin and the patch/matrix compartments of the rat caudate-putamen. J Comp Neurol, 364(1), 184–190. doi: [DOI] [PubMed] [Google Scholar]
  125. Saka E, ladarola M, Fitzgerald DJ, & Graybiel AM (2002). Local circuit neurons in the striatum regulate neural and behavioral responses to dopaminergic stimulation. Proc Natl Acad Sci U S A, 99(13), 9004–9009. doi: 10.1073/pnas.132212499 [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Salinas AG, Davis MI, Lovinger DM, & Mateo Y (2016). Dopamine dynamics and cocaine sensitivity differ between striosome and matrix compartments of the striatum. Neuropharmacology, 108, 275–283. doi: 10.1016/j.neuropharm.2016.03.049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Smith JB, Klug JR, Ross DL, Howard CD, Hollon NG, Ko VI, … Jin X (2016). Genetic-Based Dissection Unveils the Inputs and Outputs of Striatal Patch and Matrix Compartments. Neuron, 91(5), 1069–1084. doi: 10.1016/j.neuron.2016.07.046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  128. Song DD, & Harlan RE (1994). Genesis and migration patterns of neurons forming the patch and matrix compartments of the rat striatum. Brain Res Dev Brain Res, 83(2), 233–245. [DOI] [PubMed] [Google Scholar]
  129. Starr MS (1982). Influence of peptides on (3)H-dopamine release from superfused rat striatal slices. Neurochem Int, 4(4), 233–240. [DOI] [PubMed] [Google Scholar]
  130. Tennyson VM, Barrett RE, Cohen G, Cote L, Heikkila R, & Mytilineou C (1972). The developing neostriatum of the rabbit: correlation of fluorescence histochemistry, electron microscopy, endogenous dopamine levels, and ( 3 H)dopamine uptake. Brain Res, 46, 251–285. [DOI] [PubMed] [Google Scholar]
  131. Threlfell S, Lalic T, Platt NJ, Jennings KA, Deisseroth K, & Cragg SJ (2012). Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron, 75(1), 58–64. doi: 10.1016/j.neuron.2012.04.038 [DOI] [PubMed] [Google Scholar]
  132. Tinterri A, Menardy F, Diana MA, Lokmane L, Keita M, Coulpier F, … Garel S (2018). Active intermixing of indirect and direct neurons builds the striatal mosaic. Nat Commun, 9(1), 4725. doi: 10.1038/s41467-018-07171-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  133. Tokuno H, Chiken S, Kametani K, & Moriizumi T (2002). Efferent projections from the striatal patch compartment: anterograde degeneration after selective ablation of neurons expressing mu- opioid receptor in rats. Neurosci Lett, 332(1), 5–8. [DOI] [PubMed] [Google Scholar]
  134. Tremblay L, Kemel ML, Desban M, Gauchy C, & Glowinski J (1992). Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Proc Natl Acad Sci U S A, 89(23), 1121411218. doi:tre 10.1073/pnas.89.23.11214 [DOI] [PMC free article] [PubMed] [Google Scholar]
  135. Wall NR, De La Parra M, Callaway EM, & Kreitzer AC (2013). Differential innervation of direct- and indirect-pathway striatal projection neurons. Neuron, 79(2), 347–360. doi: 10.1016/j.neuron.2013.05.014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  136. Yoshizawa T, Ito M, & Doya K (2018). Reward-Predictive Neural Activities in Striatal Striosome Compartments. eNeuro, 5(1). doi: 10.1523/ENEURO.0367-17.2018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Zuccato C, Valenza M, & Cattaneo E (2010). Molecular mechanisms and potential therapeutical targets in Huntington’s disease. Physiol Rev, 90(3), 905–981. doi: 10.1152/physrev.00041.2009 [DOI] [PubMed] [Google Scholar]

RESOURCES